These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20458079)

  • 1. Failing the acid test: benefits of proton pump inhibitors may not justify the risks for many users.
    Katz MH
    Arch Intern Med; 2010 May; 170(9):747-8. PubMed ID: 20458079
    [No Abstract]   [Full Text] [Related]  

  • 2. Proton pump inhibitors: a better prescription is needed.
    Khara HS; Pitchumoni CS
    J Clin Gastroenterol; 2009 Jul; 43(6):597-8. PubMed ID: 19384247
    [No Abstract]   [Full Text] [Related]  

  • 3. Reducing the cost of proton pump inhibitors by adopting best practice.
    Hughes JD; Tanpurekul W; Keen NC; Ee HC
    Qual Prim Care; 2009; 17(1):15-21. PubMed ID: 19281670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitor utilization patterns in infants.
    Barron JJ; Tan H; Spalding J; Bakst AW; Singer J
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):421-7. PubMed ID: 18030207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Picking a PPI: it comes down to cost.
    Wigle PR; Hein B; Ellis R; Austin O; Kiesler J; Gait KA
    J Fam Pract; 2008 Apr; 57(4):231-6. PubMed ID: 18394354
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of an evidence report and policies lifting reimbursement restrictions for acid suppressants: analysis of the Belgian national database.
    van Driel ML; Vander Stichele R; Elseviers M; De Sutter A; De Maeseneer J; Christiaens T
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1113-22. PubMed ID: 18823069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical practice variations: quality of prescription of proton pump inhibitors].
    Sanjosé-Rodríguez AI; Velarde-Mayol C; Gómez De Caso-Canto JA
    Rev Calid Asist; 2012; 27(3):182-3. PubMed ID: 22463848
    [No Abstract]   [Full Text] [Related]  

  • 8. Dosing of proton pump inhibitors is suboptimal among otolaryngologists treating reflux-induced upper-respiratory disease.
    Humayun F; Hoff PT; Robinson EA; Gunaratnam NT
    Otolaryngol Head Neck Surg; 2007 Dec; 137(6):936-941. PubMed ID: 18036424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prolonged therapy with proton pump inhibitors: balance of benefits and risks].
    Lazebnik LB; Bordin DS; Masharova AA
    Eksp Klin Gastroenterol; 2010; (9):3-8. PubMed ID: 21427916
    [No Abstract]   [Full Text] [Related]  

  • 10. Failure to practice evidence-based medicine: why do physicians not treat patients with heart failure with angiotensin-converting enzyme inhibitors?
    McMurray JJ
    Eur Heart J; 1998 Oct; 19 Suppl L():L15-21. PubMed ID: 9821004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroprotective drugs in Australia: utilization patterns between 1997 and 2006 in relation to NSAID prescribing.
    Barozzi N; Tett SE
    Clin Ther; 2009 Apr; 31(4):849-61. PubMed ID: 19446158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-prescription of gastro-protectants in hospitalized patients: an analysis of what we do and what we think we do.
    Doherty GA; Cannon MD; Lynch KM; Ayoubi KZ; Harewood GC; Patchett SE; Murray FE
    J Clin Gastroenterol; 2010 Mar; 44(3):e51-6. PubMed ID: 19609216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of proton pump inhibitor cotherapy in patients taking long-term, low-dose aspirin for secondary cardiovascular prevention.
    Saini SD; Schoenfeld P; Fendrick AM; Scheiman J
    Arch Intern Med; 2008 Aug; 168(15):1684-90; discussion 1691. PubMed ID: 18695083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New AHCPR guideline targets and cost of smoking cessation programs.
    Campbell S
    Health Care Strateg Manage; 1996 Jun; 14(6):16-7. PubMed ID: 10157810
    [No Abstract]   [Full Text] [Related]  

  • 15. Should every patient with suspected upper GI bleeding receive a proton pump inhibitor while awaiting endoscopy?
    Barkun AN
    Gastrointest Endosc; 2008 Jun; 67(7):1064-6. PubMed ID: 18513549
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessing potential risks and evaluating expected benefits.
    Shaya FT; Gu A
    Manag Care Interface; 2005 May; 18(5):27-30. PubMed ID: 15941187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common ulcer drug increases risk of osteoporosis.
    Johns Hopkins Med Lett Health After 50; 2009 Jan; 20(11):7. PubMed ID: 19408411
    [No Abstract]   [Full Text] [Related]  

  • 18. The utilisation and expenditure of medicines for the prophylaxis and treatment of osteoporosis.
    McGowan B; Bennett K; Barry M; Canny M
    Ir Med J; 2008 Feb; 101(2):38-41. PubMed ID: 18450246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitor and clopidogrel interaction: fact or fiction?
    Laine L; Hennekens C
    Am J Gastroenterol; 2010 Jan; 105(1):34-41. PubMed ID: 19904241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin use in children in the United States.
    Lasky T
    Pediatrics; 2008 Dec; 122(6):1406-8; author reply 1408. PubMed ID: 19047265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.